Boston Common Asset Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-3,215
Closed -$212K – 210
2017
Q4
$212K Buy
+3,215
New +$204K 0.03% 174
2017
Q2
– Sell
-9,745
Closed -$608K – 191
2017
Q1
$608K Sell
9,745
-8,233
-46% -$496K 0.08% 152
2016
Q4
$1.04M Buy
17,978
+200
+1% +$11.8K 0.15% 110
2016
Q3
$1.06M Buy
17,778
+4,438
+33% +$273K 0.06% 185
2016
Q2
$828K Buy
13,340
+1,295
+11% +$79.7K 0.05% 198
2016
Q1
$742K Buy
12,045
+70
+0.6% +$4.13K 0.04% 212
2015
Q4
$729K Buy
+11,975
New +$712K 0.04% 217
2014
Q3
– Sell
-1,350
Closed -$64K – 320
2014
Q2
$64K Hold
1,350
– – ﹤0.01% 283
2014
Q1
$62K Buy
+1,350
New +$62.5K ﹤0.01% 319
2013
Q4
– Sell
-1,475
Closed -$64K – 357
2013
Q3
$64K Sell
1,475
-70
-5% -$2.99K ﹤0.01% 317
2013
Q2
$63K Buy
+1,545
New +$64.4K ﹤0.01% 308

Other funds holding XRAY

Boston Common Asset Management's XRAY Position: Q1 2018 in Review

Boston Common Asset Management sold out of Dentsply Sirona (XRAY) in Q1 2018, closing a stake of 3,215 shares — an estimated $212K sold.

Boston Common Asset Management first reported a position in XRAY in Q2 2013 and held it in 11 quarters. The position peaked at $1.06M in Q3 2016. 566 funds tracked by Wall St. Rank hold XRAY as of Q1 2018.

  • Boston Common Asset Management reported no remaining Dentsply Sirona position as of Q1 2018 after selling out during the quarter.
  • Boston Common Asset Management sold 3,215 Dentsply Sirona shares in Q1 2018, an estimated $212K.
  • Boston Common Asset Management first reported a position in Dentsply Sirona in Q2 2013 and held it in 11 quarters.
  • Boston Common Asset Management's Dentsply Sirona position peaked at $1.06M in Q3 2016.
  • 566 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2018.

Based on Boston Common Asset Management's 13F filing for Q1 2018, filed 26 Apr 2018.